TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

2023-2031 Report on Global Hemophilia Gene Therapy Market by Player, Region, Type, Application and Sales Channel

2023-2031 Report on Global Hemophilia Gene Therapy Market by Player, Region, Type, Application and Sales Channel

  • Category:Life Sciences
  • Published on : 23 May 2023
  • Pages :83
  • Formats:
  • Report Code:SMR-7696520
OfferClick for best price

Best Price: $2000

20232031 on Hemophilia Gene Therapy Market Size, Share 2023


This report studies the Hemophilia Gene Therapy market, covering market size for segment by type (Hemophilia A Gene Therapy, Hemophilia B Gene Therapy, etc.), by application (Hospital, Non-Hospital, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, Bioverativ, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Hemophilia Gene Therapy from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Hemophilia Gene Therapy market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of Hemophilia Gene Therapy including:

Spark Therapeutics

Ultragenyx

Shire PLC

Sangamo Therapeutics

Bioverativ

BioMarin

uniQure (CSL Behring)

Freeline Therapeutics

Pfizer

Novo Nordisk

Market split by Type, can be divided into:

Hemophilia A Gene Therapy

Hemophilia B Gene Therapy

Others

Market split by Application, can be divided into:

Hospital

Non-Hospital

Market split by Sales Channel, can be divided into:

Direct Channel

Distribution Channel

Market segment by Region/Country including:

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America (Brazil, Argentina and Colombia etc.)

Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Report Attributes Report Details
Report Title 2023-2031 Report on Global Hemophilia Gene Therapy Market by Player, Region, Type, Application and Sales Channel
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 83 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents

Chapter 1 Hemophilia Gene Therapy Market Overview
1.1 Hemophilia Gene Therapy Definition
1.2 Global Hemophilia Gene Therapy Market Size Status and Outlook (2017-2031)
1.3 Global Hemophilia Gene Therapy Market Size Comparison by Region (2017-2031)
1.4 Global Hemophilia Gene Therapy Market Size Comparison by Type (2017-2031)
1.5 Global Hemophilia Gene Therapy Market Size Comparison by Application (2017-2031)
1.6 Global Hemophilia Gene Therapy Market Size Comparison by Sales Channel (2017-2031)
1.7 Hemophilia Gene Therapy Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
Chapter 2 Hemophilia Gene Therapy Market Segment Analysis by Player
2.1 Global Hemophilia Gene Therapy Sales and Market Share by Player (2020-2022)
2.2 Global Hemophilia Gene Therapy Revenue and Market Share by Player (2020-2022)
2.3 Global Hemophilia Gene Therapy Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Hemophilia Gene Therapy Market Segment Analysis by Type
3.1 Global Hemophilia Gene Therapy Market by Type
3.1.1 Hemophilia A Gene Therapy
3.1.2 Hemophilia B Gene Therapy
3.1.3 Others
3.2 Global Hemophilia Gene Therapy Sales and Market Share by Type (2017-2022)
3.3 Global Hemophilia Gene Therapy Revenue and Market Share by Type (2017-2022)
3.4 Global Hemophilia Gene Therapy Average Price by Type (2017-2022)
3.5 Leading Players of Hemophilia Gene Therapy by Type in 2022
3.6 Conclusion of Segment by Type
Chapter 4 Hemophilia Gene Therapy Market Segment Analysis by Application
4.1 Global Hemophilia Gene Therapy Market by Application
4.1.1 Hospital
4.1.2 Non-Hospital
4.2 Global Hemophilia Gene Therapy Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of Hemophilia Gene Therapy by Application in 2022
4.4 Conclusion of Segment by Application
Chapter 5 Hemophilia Gene Therapy Market Segment Analysis by Sales Channel
5.1 Global Hemophilia Gene Therapy Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Hemophilia Gene Therapy Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of Hemophilia Gene Therapy by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Hemophilia Gene Therapy Market Segment Analysis by Region
6.1 Global Hemophilia Gene Therapy Market Size and CAGR by Region (2017-2031)
6.2 Global Hemophilia Gene Therapy Sales and Market Share by Region (2017-2022)
6.3 Global Hemophilia Gene Therapy Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Hemophilia Gene Therapy Market Share by Type
6.4.3 North America Hemophilia Gene Therapy Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Hemophilia Gene Therapy Market Share by Type
6.5.3 Europe Hemophilia Gene Therapy Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Hemophilia Gene Therapy Market Share by Type
6.6.3 Asia-Pacific Hemophilia Gene Therapy Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Hemophilia Gene Therapy Market Share by Type
6.7.3 South America Hemophilia Gene Therapy Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Hemophilia Gene Therapy Market Share by Type
6.8.3 Middle East & Africa Hemophilia Gene Therapy Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Hemophilia Gene Therapy Players
7.1 Spark Therapeutics
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Ultragenyx
7.3 Shire PLC
7.4 Sangamo Therapeutics
7.5 Bioverativ
7.6 BioMarin
7.7 uniQure (CSL Behring)
7.8 Freeline Therapeutics
7.9 Pfizer
7.10 Novo Nordisk
Chapter 8 Upstream and Downstream Analysis of Hemophilia Gene Therapy
8.1 Industrial Chain of Hemophilia Gene Therapy
8.2 Upstream of Hemophilia Gene Therapy
8.3 Downstream of Hemophilia Gene Therapy
Chapter 9 Development Trend of Hemophilia Gene Therapy (2023-2031)
9.1 Global Hemophilia Gene Therapy Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Sales Channel (2023-2031)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

LIST OF TABLES & FIGURES

List of Tables and Figures

Figure Hemophilia Gene Therapy Example
Figure Global Hemophilia Gene Therapy Revenue (Million $) Status and Outlook (2017-2031)
Figure Global Hemophilia Gene Therapy Revenue (Million $) Comparison by Region (2017-2031)
Figure Global Hemophilia Gene Therapy Revenue (Million $) Comparison by Type (2017-2031)
Figure Global Hemophilia Gene Therapy Revenue (Million $) Comparison by Application (2017-2031)
Figure Global Hemophilia Gene Therapy Revenue (Million $) Comparison by Sales Channel (2017-2031)
Table Global Hemophilia Gene Therapy Sales by Player (2020-2022)
Table Global Hemophilia Gene Therapy Sales Market Share by Player (2020-2022)
Figure Global Hemophilia Gene Therapy Sales Market Share by Player in 2022
Table Global Hemophilia Gene Therapy Revenue (Million $) by Player (2020-2022)
Table Global Hemophilia Gene Therapy Revenue Market Share by Player (2020-2022)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Player in 2022
Table Global Hemophilia Gene Therapy Average Price by Player (2020-2022)
Figure Global Hemophilia Gene Therapy Average Price by Player in 2022
Figure Global Hemophilia Gene Therapy Players Competition Situation ? Top 5 Players? Revenue Market Share in 2020
Figure Global Hemophilia Gene Therapy Players Competition Trends ? Top 5 Players? Revenue Market Share in 2022
Figure Example of Hemophilia A Gene Therapy
Figure Global Hemophilia A Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Hemophilia B Gene Therapy
Figure Global Hemophilia B Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Others
Figure Global Others Revenue (Million $) and Growth Rate (2017-2022)
Table Global Hemophilia Gene Therapy Sales by Type (2017-2022)
Table Global Hemophilia Gene Therapy Sales Market Share by Type (2017-2022)
Figure Global Hemophilia Gene Therapy Sales Market Share by Type in 2022
Table Global Hemophilia Gene Therapy Revenue (Million $) by Type (2017-2022)
Table Global Hemophilia Gene Therapy Revenue Market Share by Type (2017-2022)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Type in 2022
Table Global Hemophilia Gene Therapy Average Price by Type (2017-2022)
Figure Global Hemophilia Gene Therapy Average Price by Type in 2022
Table Leading Players of Hemophilia Gene Therapy by Type in 2022
Figure Example of Hospital
Figure Global Hemophilia Gene Therapy for Hospital Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Non-Hospital
Figure Global Hemophilia Gene Therapy for Non-Hospital Revenue (Million $) and Growth Rate (2017-2022)
Table Global Hemophilia Gene Therapy Sales by Application (2017-2022)
Table Global Hemophilia Gene Therapy Sales Market Share by Application (2017-2022)
Figure Global Hemophilia Gene Therapy Sales Market Share by Application in 2022
Table Leading Consumers of Hemophilia Gene Therapy by Application in 2022
Figure Example of Direct Channel
Figure Global Hemophilia Gene Therapy for Direct Channel Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Distribution Channel
Figure Global Hemophilia Gene Therapy for Distribution Channel Revenue (Million $) and Growth Rate (2017-2022)
Table Global Hemophilia Gene Therapy Revenue by Sales Channel (2017-2022)
Table Global Hemophilia Gene Therapy Revenue Market Share by Sales Channel (2017-2022)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Sales Channel in 2022
Table Leading Distributors/Dealers of Hemophilia Gene Therapy by Sales Channel in 2022
Table Global Hemophilia Gene Therapy Market Size and CAGR by Region (2017-2031)
Table Global Hemophilia Gene Therapy Sales by Region (2017-2022)
Table Global Hemophilia Gene Therapy Sales Market Share by Region (2017-2022)
Figure Global Hemophilia Gene Therapy Sales Market Share by Region in 2022
Table Global Hemophilia Gene Therapy Revenue (Million $) by Region (2017-2022)
Table Global Hemophilia Gene Therapy Revenue Market Share by Region (2017-2022)
Figure Global Hemophilia Gene Therapy Revenue Market Share by Region in 2022
Table North America Hemophilia Gene Therapy Sales by Country (2017-2022)
Figure North America Hemophilia Gene Therapy Sales Market Share by Country (2017-2022)
Table North America Hemophilia Gene Therapy Revenue by Country (2017-2022)
Figure North America Hemophilia Gene Therapy Revenue Market Share by Country (2017-2022)
Figure North America Hemophilia Gene Therapy Market Share by Type in 2022
Figure North America Hemophilia Gene Therapy Market Share by Application in 2022
Figure United States Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure United States Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Canada Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Canada Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Mexico Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Mexico Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Table Europe Hemophilia Gene Therapy Sales by Country (2017-2022)
Figure Europe Hemophilia Gene Therapy Sales Market Share by Country (2017-2022)
Table Europe Hemophilia Gene Therapy Revenue by Country (2017-2022)
Figure Europe Hemophilia Gene Therapy Revenue Market Share by Country (2017-2022)
Figure Europe Hemophilia Gene Therapy Market Share by Type in 2022
Figure Europe Hemophilia Gene Therapy Market Share by Application in 2022
Figure Germany Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Germany Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure UK Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure UK Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure France Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure France Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Italy Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Italy Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Russia Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Russia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Spain Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Spain Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Table Asia-Pacific Hemophilia Gene Therapy Sales by Country (2017-2022)
Figure Asia-Pacific Hemophilia Gene Therapy Sales Market Share by Country (2017-2022)
Table Asia-Pacific Hemophilia Gene Therapy Revenue by Country (2017-2022)
Figure Asia-Pacific Hemophilia Gene Therapy Revenue Market Share by Country (2017-2022)
Figure Asia-Pacific Hemophilia Gene Therapy Market Share by Type in 2022
Figure Asia-Pacific Hemophilia Gene Therapy Market Share by Application in 2022
Figure China Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure China Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Japan Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Japan Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Korea Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Korea Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure India Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure India Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Southeast Asia Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Southeast Asia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Australia Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Australia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Table South America Hemophilia Gene Therapy Sales by Country (2017-2022)
Figure South America Hemophilia Gene Therapy Sales Market Share by Country (2017-2022)
Table South America Hemophilia Gene Therapy Revenue by Country (2017-2022)
Figure South America Hemophilia Gene Therapy Revenue Market Share by Country (2017-2022)
Figure South America Hemophilia Gene Therapy Market Share by Type in 2022
Figure South America Hemophilia Gene Therapy Market Share by Application in 2022
Figure Brazil Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Brazil Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Argentina Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Argentina Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Colombia Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Colombia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Table Middle East & Africa Hemophilia Gene Therapy Sales by Country (2017-2022)
Figure Middle East & Africa Hemophilia Gene Therapy Sales Market Share by Country (2017-2022)
Table Middle East & Africa Hemophilia Gene Therapy Revenue by Country (2017-2022)
Figure Middle East & Africa Hemophilia Gene Therapy Revenue Market Share by Country (2017-2022)
Figure Middle East & Africa Hemophilia Gene Therapy Market Share by Type in 2022
Figure Middle East & Africa Hemophilia Gene Therapy Market Share by Application in 2022
Figure UAE Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure UAE Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Saudi Arabia Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure Saudi Arabia Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Figure South Africa Hemophilia Gene Therapy Sales and Growth Rate (2017-2022)
Figure South Africa Hemophilia Gene Therapy Revenue (Million $) and Growth Rate (2017-2022)
Table Company Snapshot of Spark Therapeutics
Table Hemophilia Gene Therapy Introduction of Spark Therapeutics
Table Hemophilia Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share of Spark Therapeutics (2020-2022)
Table Industrial Chain of Hemophilia Gene Therapy
Table Manufacturing Cost Structure of Hemophilia Gene Therapy
Table General Manufacturing Process of Hemophilia Gene Therapy
Table Leading Distributors/Dealers of Hemophilia Gene Therapy
Table Leading Consumers of Hemophilia Gene Therapy
Figure Global Hemophilia Gene Therapy Sales and Growth Rate Forecast (2023-2031)
Figure Global Hemophilia Gene Therapy Revenue and Growth Rate Forecast (2023-2031)
Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Region (2023-2031)
Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Type (2023-2031)
Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Application (2023-2031)
Table Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Sales Channel (2023-2031)

REPORT PURCHASE OPTIONS

USD Single User License
USD Enterprise License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount